We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$17.5B
AUM Growth
-$1.1B
Cap. Flow
-$1.74B
Cap. Flow %
-9.95%
Top 10 Hldgs %
16.94%
Holding
1,448
New
484
Increased
421
Reduced
286
Closed
239

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$277M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$266M
3
CMCSA icon
Comcast
CMCSA
+$205M
4
BAC icon
Bank of America
BAC
+$181M
5
SHPG
Shire pic
SHPG
+$147M

Sector Composition

Rank Sector Weight
1 Healthcare 21.47%
2 Technology 20.74%
3 Financials 17.87%
4 Industrials 10.42%
5 Consumer Discretionary 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACH
1176
DELISTED
Alum Corp of China Ltd
ACH
$227K ﹤0.01%
+19,676
New +$213K
RYN icon
1177
Rayonier
RYN
$6.55B
$218K ﹤0.01%
+8,617
New +$231K
SRGA
1178
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$218K ﹤0.01%
1,396
CTBI icon
1179
Community Trust Bancorp
CTBI
$1.41B
$217K ﹤0.01%
+5,934
New +$212K
ARMK icon
1180
Aramark
ARMK
$14.7B
$214K ﹤0.01%
+9,507
New +$194K
SFY
1181
DELISTED
SWIFT ENERGY CO (HOLDING COMPANY)
SFY
$214K ﹤0.01%
+52,870
New +$316K
INFI
1182
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$212K ﹤0.01%
+12,547
New +$183K
CCK icon
1183
Crown Holdings
CCK
$13.1B
$211K ﹤0.01%
+4,138
New +$199K
RVNC
1184
DELISTED
Revance Therapeutics, Inc.
RVNC
$206K ﹤0.01%
+12,161
New +$212K
SLM icon
1185
SLM Corp
SLM
$5.15B
$201K ﹤0.01%
+19,687
New +$188K
SMRT
1186
DELISTED
Stein Mart Inc
SMRT
$200K ﹤0.01%
13,648
+1,783
+15% +$24K
KE
1187
Kimball Electronics
KE
$628M
$194K ﹤0.01%
+16,173
New +$173K
TGA
1188
DELISTED
Transglobe Energy Corp
TGA
$192K ﹤0.01%
46,033
+6,216
+16% +$25.6K
ESI
1189
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
$176K ﹤0.01%
+18,300
New +$156K
ZVO
1190
DELISTED
Zovio Inc. Common Stock
ZVO
$173K ﹤0.01%
+15,260
New +$174K
LTM
1191
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$159K ﹤0.01%
+13,274
New +$154K
PETS icon
1192
PetMed Express
PETS
$42.3M
$157K ﹤0.01%
+10,902
New +$147K
PT
1193
DELISTED
PORTUGAL TELECOM SGPS, S.A.
PT
$142K ﹤0.01%
+134,007
New +$210K
YZC
1194
DELISTED
Yanzhou Coal Mining
YZC
$136K ﹤0.01%
+16,173
New +$134K
WNEB icon
1195
Western New England Bancorp
WNEB
$275M
$130K ﹤0.01%
17,739
ENZN
1196
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$126K ﹤0.01%
115,380
IL
1197
DELISTED
IntraLinks Holdings Inc.
IL
$121K ﹤0.01%
10,139
-145,845
-93% -$1.42M
ERF
1198
DELISTED
Enerplus Corporation
ERF
$119K ﹤0.01%
12,358
-596,781
-98% -$8.06M
LEE icon
1199
Lee Enterprises
LEE
$182M
$117K ﹤0.01%
3,191
SSRG
1200
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
$116K ﹤0.01%
+14,916
New +$113K

Similar funds

Arrowstreet Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Arrowstreet Capital held 1,448 positions worth $17.5B, down 5.9% from $18.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Arrowstreet Capital withdrew a net $1.74B in Q4 2014, closing 239 positions and reducing 286 holdings. Its most notable exit was Apple, an estimated $762M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

Against the trend, Arrowstreet Capital opened a new position in Bank of America worth $189M.

  • Arrowstreet Capital's largest Q4 2014 buy was Bank of America: 10,575,571 shares worth $189M.
  • Arrowstreet Capital added most to Citigroup in Q4 2014, an estimated $277M increase.
  • Arrowstreet Capital's biggest Q4 2014 reduction was Philip Morris, cutting an estimated $366M.
  • Arrowstreet Capital fully exited Apple in Q4 2014, selling an estimated $762M.
  • Arrowstreet Capital's ten largest holdings make up 17% of its $17.5B portfolio in Q4 2014.
  • Arrowstreet Capital opened 484 new positions and closed 239 in Q4 2014.
  • Arrowstreet Capital's portfolio value fell 5.9% quarter-over-quarter to $17.5B.

Based on Arrowstreet Capital's 13F filing for Q4 2014, filed 13 Feb 2015.